Syndax Pharmaceuticals Inc

SNDX Nasdaq SEC CIK 1395937
Follow Syndax Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $83.3M +81.6% vs same quarter last year
Net income −$49.4M +18.6% vs same quarter last year
EPS, diluted −$0.55 +21.4% vs same quarter last year
Operating cash flow −$27.3M +61.4% vs same quarter last year
Revenue by quarter
$7.7M
$20M
$38M
$45.9M
$68.7M
$64.9M
$72.8M
$83.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income13 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$172.4M−$285.4M
FY24$23.7M−$318.8M
FY23$0−$209.4M
FY22$0−$149.3M
FY21$139.7M$24.9M
FY20$1.5M−$73.2M
FY19$1.5M−$56M
FY18$1.5M−$74M
FY17$2.1M−$60.8M
FY16$1.2M−$44.5M
FY15$627K−$24.1M
FY14-−$19.8M
FY13--
MarginsShare of revenue
  • Operating margin
  • Net margin
−6000%−4000%−2000%0%2000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−158.4%−165.6%
FY24−1434.4%−1346.3%
FY23--
FY22--
FY2118.8%17.8%
FY20−4708.2%−4822.5%
FY19−3792.9%−3694.6%
FY18−5001.7%−4875.5%
FY17−2939%−2884.3%
FY16−3587.4%−3645.2%
FY15−3271.6%−3846.7%
FY14--
FY13--
Free cash flowOperating cash flow minus capital expenditure
−$400M−$300M−$200M−$100M$0$100MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$323.2M
FY24−$274.9M
FY23−$160.6M
FY22−$133.7M
FY21$29M
FY20−$71.3M
FY19-
FY18−$68.7M
FY17−$47.5M
FY16−$35.4M
FY15−$2.5M
FY14−$14.4M
FY13-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Syndax Pharmaceuticals
  • Healthcare median
−6000%−4000%−2000%0%2000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearSyndax PharmaceuticalsHealthcare median
FY25−165.6%−30.6%
FY24−1346.3%−47%
FY23-−58%
FY22-−80.4%
FY2117.8%−71.8%
FY20−4822.5%−62.2%
FY19−3694.6%−46.2%
FY18−4875.5%−49.6%
FY17−2884.3%−45.9%
FY16−3645.2%−36%
FY15−3846.7%−37.8%
FY14-−35.5%
FY13-−37.1%